Anika Therapeutics Q3 Adj. EPS $0.29 Beats $0.06 Estimate, Sales $30.594M Beat $29.436M Estimate
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.06 by 383.33 percent. This is a 625 percent increase over earnings of $0.04 per share from
Share
Why It Matters
Anika Therapeutics made much more money than experts thought it would. When a company beats expectations by a lot, it shows the business is doing really well.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.